# Intellia (NTLA) — Analyst Forecast

NTLA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ntla/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 6, 2026 | Barclays | Initiated Coverage | Underweight | $8.00 |
| Sep 9, 2026 | HC Wainwright & Co. | Maintained | Buy | $25.00 |
| Sep 9, 2026 | Wedbush | Maintained | Neutral | $13.00 |
| Sep 9, 2026 | Citizens | Maintained | Market Outperform | $30.00 |
| Aug 25, 2026 | Citizens | Maintained | Market Outperform | $30.00 |
| Aug 7, 2026 | Evercore ISI Group | Upgraded | In-Line → Outperform | $24.00 |
| Jul 16, 2026 | Wolfe Research | Downgraded | Peer Perform → Underperform | $9.00 |
| Jul 10, 2026 | Wedbush | Maintained | Neutral | $17.00 |
| Jun 16, 2026 | Canaccord Genuity | Maintained | Buy | $49.00 |
| Jun 15, 2026 | HC Wainwright & Co. | Maintained | Buy | $25.00 |
| Jun 15, 2026 | Wedbush | Maintained | Neutral | $12.00 |
| Jun 15, 2026 | Citizens | Maintained | Market Outperform | $30.00 |
| May 13, 2026 | HC Wainwright & Co. | Maintained | Buy | $25.00 |
| May 13, 2026 | Bernstein | Maintained | Market Perform | $17.00 |
| May 12, 2026 | Wedbush | Maintained | Neutral | $12.00 |
| May 12, 2026 | Canaccord Genuity | Maintained | Buy | $49.00 |
| Apr 28, 2026 | Morgan Stanley | Maintained | Equal-Weight | $15.00 |
| Apr 28, 2026 | Goldman Sachs | Maintained | Sell | $9.00 |
| Apr 28, 2026 | Canaccord Genuity | Maintained | Buy | $58.00 |
| Apr 28, 2026 | Citizens | Maintained | Market Outperform | $30.00 |

## Frequently Asked Questions

### What is the latest analyst rating on NTLA?

On Oct 6, 2026, Barclays initiated coverage of Intellia at Underweight with a price target of $8.00.

## Similar Stocks

- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares
- [BEAM](https://www.lighthorse.io/tickers/beam) — Beam Therapeutics Inc. - Common Stock
- [EDIT](https://www.lighthorse.io/tickers/edit) — Editas Medicine, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).